SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?


To: Premier who wrote (1109)2/24/1998 3:06:00 PM
From: Sam  Read Replies (1) | Respond to of 2068
 
Texas Pacific's terms of endearment, according to Yahoo:

"Under the terms of the definitive agreement, Texas Pacific will purchase $350 million in preferred stock issued
as Series A and Series B with dividend rates of 8% and 9% respectively. The preferred shares also come with
warrants to acquire 22.5 million shares of Oxford common stock with a strike price of $17.75. This price
represents a 5% premium over the average trading price of Oxford shares for 30 trading days ended February 20,
1998. The strike price is to become 115% of the average trading price of Oxford common stock for the 20 trading
days following the filing of the Company's annual report on Form 10-K for the year ending December 31, 1998, if
such adjustment would reduce the strike price.

(My note: wish I could get some of the convertible, too!)

The Series A Preferred Stock will carry a dividend of 8% and will be issued with warrants to purchase 15,800,000
shares of common stock, or 19.9% of the present outstanding voting power of Oxford's common stock. The
Series A Preferred Stock will have 16.6% of the combined voting power of Oxford's outstanding common stock
and the Series A shares. The Series B Preferred Stock, which will be issued with warrants to purchase
non-voting junior participating preferred stock, is non-voting and will carry a dividend of 9%. The Series B
Preferred Stock will become voting, the dividend rate will decrease to 8% and the related warrants will be
exercisable for 6,730,000 shares of common stock at such time as Oxford's shareholders approve the increase in
voting rights of Texas Pacific to 22.1%. The equity financing is subject to various conditions, which include
regulatory approvals, completion of the debt financing and expiration of the requisite waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act. Closing is not subject to shareholder approval."